135 related articles for article (PubMed ID: 8927031)
1. In vivo modulation of N-myristoyltransferase activity by orthovanadate.
King MJ; Pugazhenthi S; Khandelwal RL; Sharma RK
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):151-5. PubMed ID: 8927031
[TBL] [Abstract][Full Text] [Related]
2. Membrane-associated N-myristoyltransferase activity is reduced in obese (fa/fa) Zucker rat liver.
King MJ; Pugazhenthi S; Khandelwal RL; Sharma RK
Biochem Biophys Res Commun; 1993 Oct; 196(2):665-70. PubMed ID: 8240341
[TBL] [Abstract][Full Text] [Related]
3. Potential role of N-myristoyltransferase in pathogenic conditions.
Sharma RK
Can J Physiol Pharmacol; 2004 Oct; 82(10):849-59. PubMed ID: 15573145
[TBL] [Abstract][Full Text] [Related]
4. Elevated N-myristoyl transferase activity is reversed by sodium orthovanadate in streptozotocin-induced diabetic rat.
King MJ; Pugazhenthi S; Khandelwal RL; Sharma RK
Biochim Biophys Acta; 1993 Jan; 1165(3):259-62. PubMed ID: 8418883
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats.
Marzban L; Bhanot S; McNeill JH
Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716
[TBL] [Abstract][Full Text] [Related]
6. Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zucker rat.
Pugazhenthi S; Hussain A; Yu B; Brownsey RW; Angel JF; Khandelwal RL
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):211-5. PubMed ID: 8927041
[TBL] [Abstract][Full Text] [Related]
7. Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver.
Pugazhenthi S; Tanha F; Dahl B; Khandelwal RL
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):125-9. PubMed ID: 8927027
[TBL] [Abstract][Full Text] [Related]
8. Mammalian myristoyl CoA: protein N-myristoyltransferase.
Raju RV; Magnuson BA; Sharma RK
Mol Cell Biochem; 1995; 149-150():191-202. PubMed ID: 8569729
[TBL] [Abstract][Full Text] [Related]
9. In vivo effects of vanadium in diabetic rats are independent of changes in PI-3 kinase activity in skeletal muscle.
Mohammad A; Bhanot S; McNeill JH
Mol Cell Biochem; 2001 Jul; 223(1-2):103-8. PubMed ID: 11681710
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of bovine brain N-myristoyltransferase(s) by a cytosolic activator.
King MJ; Sharma RK
Biochem Biophys Res Commun; 1995 Jul; 212(2):580-8. PubMed ID: 7626073
[TBL] [Abstract][Full Text] [Related]
11. Hepatic delta9, delta6, and delta5 desaturations in non-insulin-dependent diabetes mellitus eSS rats.
Montanaro MA; Rimoldi OJ; Igal RA; Montenegro S; Tarrés MC; Martínez SM; Brenner RR
Lipids; 2003 Aug; 38(8):827-32. PubMed ID: 14577661
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of NIP71 on N-myristoyltransferase activity.
King MJ; Sharma RK
Mol Cell Biochem; 1994 Dec; 141(2):79-86. PubMed ID: 7891674
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme A dependent myristoylation and demyristoylation in the regulation of bovine spleen N-myristoyltransferase.
Raju RV; Sharma RK
Mol Cell Biochem; 1996 May; 158(2):107-13. PubMed ID: 8817471
[TBL] [Abstract][Full Text] [Related]
14. Detection of myristoyl CoA:protein N-myristoyltransferase activity by ion-exchange chromatography.
Paige LA; Chafin DR; Cassady JM; Geahlen RL
Anal Biochem; 1989 Sep; 181(2):254-8. PubMed ID: 2817389
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase B in the diabetic heart.
Huisamen B
Mol Cell Biochem; 2003 Jul; 249(1-2):31-8. PubMed ID: 12956395
[TBL] [Abstract][Full Text] [Related]
16. Myristoyl CoA:protein N-myristoyltransferase: subcellular localization, activation and kinetic behavior in the presence of organic solvents.
Rajala RV; Sharma RK
Biochem Biophys Res Commun; 1995 Mar; 208(2):617-23. PubMed ID: 7695615
[TBL] [Abstract][Full Text] [Related]
17. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
Duronio RJ; Jackson-Machelski E; Heuckeroth RO; Olins PO; Devine CS; Yonemoto W; Slice LW; Taylor SS; Gordon JI
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1506-10. PubMed ID: 2406721
[TBL] [Abstract][Full Text] [Related]
18. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
Meyerovitch J; Backer JM; Kahn CR
J Clin Invest; 1989 Sep; 84(3):976-83. PubMed ID: 2547842
[TBL] [Abstract][Full Text] [Related]
19. Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound.
Clark TA; Edel AL; Heyliger CE; Pierce GN
Can J Physiol Pharmacol; 2004 Oct; 82(10):888-94. PubMed ID: 15573149
[TBL] [Abstract][Full Text] [Related]
20. Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.
Park SH; Marso SP; Zhou Z; Foroudi F; Topol EJ; Lincoff AM
Circulation; 2001 Aug; 104(7):815-9. PubMed ID: 11502708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
